The use of polyclonal intravenous immunoglobulins in the prevention and treatment of infectious diseases

Acta Clinica Belgica

Volumn 55, Issue 3, 2000, Pages 163-169

  Lories, R J U ^a   Maertens, J A ^a   Ceuppens, J L ^a   Peetermans, W E ^a  

^a UZ Gathuisberg ^*  (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BELGIUM; BLOOD SAMPLING; BONE MARROW TRANSPLANTATION; CYTOMEGALOVIRUS INFECTION; HUMAN; INFECTION; ORGAN TRANSPLANTATION; POLYCLONAL ACTIVATION; REVIEW; SECONDARY IMMUNE RESPONSE; SEPSIS;

EID: 0033766684     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.1080/17843286.2000.11754288     Document Type: Review

References (35)

1. The use of i intravenous immune globulin in immunodeficiency diseases
2. Comparison of high-dose and low-dose intravenous immunogloblin therapy in patients with primary immunedeficiency diseases
3. Primary immunodeficiency diseases: Report of a WHO sponsored meeting
4. Human IgG subclasses and their relation to carbohydrate antigen immuno-competence
5. Cooperative group for the study of Immunoglobulin in chronic lymphocytic leukemia. Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukemia
6. Immunoglobulin replacement in patients with chronic lymphocytic leukaemia: Comparison of two dose regimens
7. Effect of various doses of intravenous polyclonal IgG on in vivo levels of 12 pneumococcal antibodies in patients with chronic lymphocytic leukaemia and multiple myeloma
8. Randomized trial of intravenous immunoglobulin prophylaxis for patients with chronic lymphocytic leukaemia and secondary hypogammaglobulinaemia
9. Treatment of hypogammaglobulinaemia in chronic lymphocytic leukaemia by low-dose intravenous gammaglobulin
10. Randomized trial of intravenous immunoglobulin as prophylaxis against infection in plateau-phase multiple myeloma
11. Efficacy of immune globulin in preventing complications of bone marrow transplantation: A meta-analysis
12. Reduction in transplant-related complications in patients given intravenous immuno globulin after allogeneic marrow transplantation
13. Does high-dose intravenous immune globulin treatment after bone marrow transplantation increase mortality in veno-occlusive disease of the liver?
14. High-dose weekly intravenous immunoglobulin to prevent infections in patients undergoing autologous bone marrow transplantation and severe myelosuppressive therapy
15. Intravenous immune globulin for the prevention of bacterial infections in children with symptomatic human immunodeficiency virus infection
16. Use of intravenous immunoglobulin in acquired immune deficiency syndrome
17. A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation
18. A randomized trial of high dose polyvalent intravenous immunoglobulin (HGIgG) vs Cytomegalovirus (CMV) hyperimmune IgG in allogeneic hemopoietic stem cell transplants
19. Immunomodulatory antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation
20. Cytomegalovirus viremia in lung transplant recipients recieving gancyclovir and immune globulin
21. Prophylaxis and management of cytomegalovirus pneumonitis after lung transplantation: A review of experience in one center
22. Randomized comparison of gancyclovir plus intravenous immune globulin (IVIG) with IVIG alone for prevention of primary cytomegalovirus disease in children recieving liver transplants
23. Cytomegalovirus immune globulin prophylaxis in liver transplantation. A randomized, double-blind, placebo-controlled trial
24. Intravenous immunoglobulin prophylaxis of cytomegalovirus infection in pediatric renal transplant recipients
25. Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients
26. Prophylaxis of primary cytomegalovirus disease in renal transplant recipients
27. Hyperimmunoglobulin for cytomegalovirus prophylaxis following heart transplantation
28. Cytomegalovirus hyperimmunoglboulin prophylaxis of cytomegalovirus infection in immunosuppressed heart transplant recipients
29. Cytomegalovirus infection prophylaxis in heart transplantation
30. Prospective randomized trial of efficy of ganciclovir versus that of anti-cytomegalovirus (CMV) immunoglobulin to prevent C.M.V. disease in CMV-seropositive heart transplant recipients treated with OKT3
31. The role of intravenous immunoglobulin for the prevention and treatment of neonatal sepsis
32. Supplemental immune globulin in sepsis: A critical appraisal
33. Clinical relevance of superantigens and their in vivo response to intravenous immunoglobulin therapy
34. Intravenous immunoglobulin therapy for streptoccal toxic shock syndrome. A comparative observational study
35. Use of intravenous immune globulin in addition to antiviral therapy in the treatment of C.M.V. gastro-intestinal disease in allogeneic bone marrow transplant patients: A report from the European Group for Blood Marrow Transplantation